Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debayan Mukherjee

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Radiation Research|November 5, 2011
The in vivo expression of radiation-induced chromosomal instability has an inflammatory mechanismDebayan Mukherjee, Philip J Coates, Sally A Lorimore, et al.
The Journal of Pathology|November 21, 2013
Responses to ionizing radiation mediated by inflammatory mechanismsDebayan Mukherjee, Philip J Coates, Sally A Lorimore, et al.
International Journal of Radiation Biology|October 20, 2012
Radiation-induced bone marrow apoptosis, inflammatory bystander-type signaling and tissue cytotoxicityDebayan Mukherjee, Philip J Coates, Shubhra Rastogi, et al.
Radiation Research|April 13, 2013
The influence of p53 functions on radiation-induced inflammatory bystander-type signaling in murine bone marrowSally A Lorimore, Shubhra Rastogi, Debayan Mukherjee, et al.
BMC Cancer|November 25, 2021
The effect of hypoxia on PD-L1 expression in bladder cancerVicky Smith, Debayan Mukherjee, Sapna Lunj, et al.
Cancer Research|September 10, 2011
Long-lived inflammatory signaling in irradiated bone marrow is genome dependentSally A Lorimore, Debayan Mukherjee, Joanne I Robinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2022
Radiotherapy transiently reduces the sensitivity of cancer cells to lymphocyte cytotoxicityKaroliina Tuomela, Debayan Mukherjee, Ashley R Ambrose, et al.
Cancers|January 8, 2023
Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder CancerVicky Smith, Debayan Mukherjee, Anna Maria Tsakiroglou, et al.
EMBO Molecular Medicine|November 1, 2017
Akt inhibition improves long-term tumour control following radiotherapy by altering the microenvironmentEmma J Searle, Brian A Telfer, Debayan Mukherjee, et al.
Frontiers in Immunology|June 12, 2023
The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapyJamie Frankish, Debayan Mukherjee, Erminia Romano, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Radiation Research|November 5, 2011
The in vivo expression of radiation-induced chromosomal instability has an inflammatory mechanismDebayan Mukherjee, Philip J Coates, Sally A Lorimore, et al.
The Journal of Pathology|November 21, 2013
Responses to ionizing radiation mediated by inflammatory mechanismsDebayan Mukherjee, Philip J Coates, Sally A Lorimore, et al.
International Journal of Radiation Biology|October 20, 2012
Radiation-induced bone marrow apoptosis, inflammatory bystander-type signaling and tissue cytotoxicityDebayan Mukherjee, Philip J Coates, Shubhra Rastogi, et al.
Radiation Research|April 13, 2013
The influence of p53 functions on radiation-induced inflammatory bystander-type signaling in murine bone marrowSally A Lorimore, Shubhra Rastogi, Debayan Mukherjee, et al.
BMC Cancer|November 25, 2021
The effect of hypoxia on PD-L1 expression in bladder cancerVicky Smith, Debayan Mukherjee, Sapna Lunj, et al.
Cancer Research|September 10, 2011
Long-lived inflammatory signaling in irradiated bone marrow is genome dependentSally A Lorimore, Debayan Mukherjee, Joanne I Robinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2022
Radiotherapy transiently reduces the sensitivity of cancer cells to lymphocyte cytotoxicityKaroliina Tuomela, Debayan Mukherjee, Ashley R Ambrose, et al.
Cancers|January 8, 2023
Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder CancerVicky Smith, Debayan Mukherjee, Anna Maria Tsakiroglou, et al.
EMBO Molecular Medicine|November 1, 2017
Akt inhibition improves long-term tumour control following radiotherapy by altering the microenvironmentEmma J Searle, Brian A Telfer, Debayan Mukherjee, et al.
Frontiers in Immunology|June 12, 2023
The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapyJamie Frankish, Debayan Mukherjee, Erminia Romano, et al.
Pageof 2